 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
8-9-2023
Insider Buy |
Elizabeth Barrett
|
$18.64
CAGR »
|
$37,278.60
2,000 shares |
5-9-2023
Insider Buy |
Elizabeth Barrett
|
$50.50
CAGR »
|
$50,500.00
1,000 shares |
11-10-2022
Insider Buy |
Barry E. Greene
President and CEO |
$34.48
CAGR »
|
$500,022.35
14,500 shares |
5-5-2022
Insider Buy |
George Golumbeski
|
$31.45
CAGR »
|
$251,563.20
8,000 shares |
8-5-2021
Insider Buy |
Barry E. Greene
President and CEO |
$43.15
CAGR »
|
$1,020,054.18
23,640 shares |
6-16-2021
Insider Buy |
James M. Frates
|
$55.10
CAGR »
|
$99,734.62
1,810 shares |
6-16-2021
Insider Buy |
Barry E. Greene
President and CEO |
$56.32
CAGR »
|
$495,627.44
8,800 shares |
6-16-2021
Insider Buy |
Kevin P. Starr
|
$56.05
CAGR »
|
$999,983.44
17,842 shares |
12-9-2019
Insider Buy |
Jeffrey M. Jonas
President & CEO |
$64.20
CAGR »
|
$481,500.00
7,500 shares |
12-9-2019
Insider Buy |
Albert Robichaud
Chief Scientific Officer |
$64.16
CAGR »
|
$1,604,000.00
25,000 shares |
1-7-2016
Insider Buy |
Jeffrey M. Jonas
See Remarks |
$49.56
CAGR »
|
$11,200.56
226 shares |
1-7-2016
Insider Buy |
Kimi Iguchi
CFO, Secretary and Treasurer |
$49.56
CAGR »
|
$8,722.56
176 shares |
7-23-2014
Insider Buy |
Kimi Iguchi
See Remarks |
$18.00
CAGR »
|
$108,000.00
6,000 shares |
7-23-2014
Insider Buy |
Stephen Kanes
Chief Medical Officer |
$18.00
CAGR »
|
$54,000.00
3,000 shares |
7-23-2014
Insider Buy |
James M. Frates
Director |
$18.00
CAGR »
|
$90,000.00
5,000 shares |
7-23-2014
Insider Buy |
Jeffrey M. Jonas
See Remarks |
$18.00
CAGR »
|
$108,000.00
6,000 shares |
7-23-2014
Insider Buy |
Thomas Anderson
See Remarks |
$18.00
CAGR »
|
$108,000.00
6,000 shares |
7-23-2014
Insider Buy |
Albert Robichaud
Chief Scientific Officer |
$18.00
CAGR »
|
$72,000.00
4,000 shares |
7-23-2014
Insider Buy |
Steven M. Paul
Director |
$18.00
CAGR »
|
$180,000.00
10,000 shares |
Also See: Institutional Holders of SAGE
Also See: SEC filings
Below we present the annualized performance delivered by SAGE stock since 8-9-2023 (the date of the most recent
insider purchase). The performance of the investment from the time SAGE insider buying occurred is the ultimate
test of whether insiders were right about SAGE being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
08/10/2023 |
|
| End date: |
04/25/2024 |
|
| Start price/share: |
$19.36 |
|
| End price/share: |
$13.58 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-29.86% |
|
| Annualized Gain: |
-42.07% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$7,014.00 |
|
| Years: |
0.71 |
|
SAGE Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent SAGE insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding SAGE
|
|
Free SAGE Email Alerts:
